Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy

Metabolism: Clinical and Experimental

Volumn 50, Issue 2, 2001, Pages 207-215

  O'Byrne, Dawn ^a   Devaraj, Sridevi ^a   Islam, Kazi Nazrul ^a   Collazo, Roberto ^a   McDonald, Lauren ^a   Grundy, Scott ^a   Jialal, Ishwarlal ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AUTOANTIBODY; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN; METHYLGLYOXAL; OXIDIZED LOW DENSITY LIPOPROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; ATHEROGENESIS; CELL ADHESION; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MALE; MONOCYTE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; TUMOR CELL LINE; VITAMIN SUPPLEMENTATION;

EID: 0035116227     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2001.19486     Document Type: Article

References (76)

1. Accelerated atherosclerosis in prolonged maintenance hemodialysis
2. Morbidity and mortality on maintenance haemodialysis
3. Cardiovascular disease in chronic renal disease: Clinical epidemiology of cardiovascular disease in chronic renal disease
4. Atherogenesis and cardiac death: Are they related to dialysis procedure and biocompatibility?
5. Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis?
6. Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis
7. Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis: Effects of fish oil and vitamin E administration
8. Effect of α-tocopherol on in vitro and in vivo metabolism of low-density lipoproteins in haemodialysis patients
9. Oxidation of low density lipoprotein in patients on regular haemodialysis
10. Oxidation of low-density lipoproteins from patients with renal failure or renal transplants
11. Resistance of lipoproteins from continuous ambulatory peritoneal dialysis patients to in vitro oxidation
12. Oxidation of low density lipoprotein in hemodialysis patients: Effect of dialysis and comparison with matched controls
13. Oxidative stress in haemodialysis
14. Evidence for oxidative stress during in vitro dialysis
15. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure
16. Inflammation, dyslipidemia and vascular risk factors in hemodialysis patients
17. Hyperlipidemia in patients with chronic renal disease
18. Accumulation of lipoprotein remnants in patients with chronic renal failure
19. Increased lipoprotein-remnant formation in chronic renal failure
20. Lipoprotein glycation and its metabolic consequences
21. Glycation accelerates the oxidation of low density lipoprotein by copper ions
22. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency
23. The role of advanced glycosylation end-products in the pathogenesis of atherosclerosis
24. Increased advanced glycation end products in atherosclerotic lesions of patients with end-stage renal disease
25. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid
26. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins
27. Atherogenic lipids, vascular dysfunction, and clinical signs of ischemic heart disease
28. Atherosclerosis - An inflammatory disease
29. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions
30. Endothelial cells and atherosclerosis: Lipoprotein metabolism, matrix, interactions, and monocyte recruitment
31. The role of adhesion molecules in atherosclerosis
32. Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients
33. Alterations in soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in hemodialysis patients
34. Vitamin E consumption and the risk of coronary disease in women
35. Vitamin E consumption and risk of coronary heart disease in men
36. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge heart antioxidant study (CHAOS)
37. The effect of alpha-tocopherol supplementation on LDL oxidation. A dose-response study
38. Improvement of endothelial vasomotor dysfunction by treatment with alpha-tocopherol in patients with high remnant lipoproteins levels
39. Effect of vitamin E on endothelial vasodilator function in patients with hypercholesterolemia, chronic smoking or both
40. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy
41. Direct transesterification of all classes of lipids in a one-step reaction
42. Simultaneous determination of retinol, α-tocopherol and β-carotene in serum by isocratic high-performance liquid chromatography
43. The use of different lipids to express serum tocopherol: Lipid ratios for the measurement of vitamin E status
44. Protein measurement with the Folin phenol reagent
45. Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus
46. The effects of alpha tocopherol supplementation on monocyte function: Decreased lipid oxidation, interleukin 1β secretion, and monocyte adhesion to endothelium
47. A new assay for the measurement of the attachment of neutrophils and other cell types to endothelial cells
48. Alterations in nonenzymatic biochemistry in uremia: Origin and significance of "carbonyl stress" in long-term uremic complications
49. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: Is there oxidative stress in uremia?
50. Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure
51. Determination of methylglyoxal as 2-methylquinoxaline by high-performance liquid chromatography and its application to biological samples
52. Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells
53. Mononuclear leukocytes exposed to oxidized low density lipoprotein secrete a factor that stimulates endothelial cells to express adhesion molecules
54. Autoantibodies against modified low density lipoprotein: Nonlipid factor of blood plasma that stimulates foam cell formation
55. Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis
56. Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk
57. Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls
58. Autoantibody against oxidized LDL and progression of carotid atherosclerosis
59. LDL enhances monocyte adhesion to endothelial cells in vitro
60. Homocyst(e)ine: An important risk factor for atherosclerotic vascular disease
61. Homocysteine, a new crucial element in the pathogenesis of uremic cardiovascular complications
62. Characterization of the adduct formed from the reaction between homocysteine thiolactone and low-density lipoprotein: Antioxidant implications
63. Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats in vivo
64. Mechanisms of thrombogenesis and accelerated atherogenesis in homocysteinaemia
65. Glyc-oxidized LDL impair endothelial function more potently than oxidized LDL: Role of enhanced oxidative stress
66. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes
67. Circulating adhesion molecules during kidney allograft rejection
68. Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: Pathological significance
69. Changes of adhesion molecules and soluble ICAM-1 during hemodialysis (HD) with cellulosic dialyzers
70. The significance of adhesion molecules in nephrology
71. Soluble vascular cell adhesion molecule-1 as a biohumeral correlate of atherosclerosis
72. Endothelium-dependent vasodilation and distensibility of large arteries in chronic haemodialysis patients
73. Endothelium-dependent vasodilation is impaired in peritoneal dialysis patients
74. Effect of alpha tocopherol supplementation on cell function in type 2 diabetic subjects with and without macrovascular complications
75. Vitamin E inhibits low-density lipoprotein-induced adhesion of monocytes to human aortic endothelial cells in vitro